Patents by Inventor Fritz ANDREAE

Fritz ANDREAE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synthesis of prostate specific membrane antigen (PSMA) ligands
    Patent number: 12655115
    Abstract: The present disclosure relates to the synthesis of prostate specific membrane antigen (PSMA) ligands that are useful in the treatment of diseases like cancer. In particular, the disclosure relates to a method for synthesizing PSMA ligands having a glutamate-urea-lysine (GUL) moiety and a chelating agent that can comprise a radiometal.
    Type: Grant
    Filed: November 19, 2021
    Date of Patent: June 16, 2026
    Assignee: NOVARTIS AG
    Inventor: Fritz Andreae
  • SYNTHESIS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS
    Publication number: 20240025866
    Abstract: The present disclosure relates to the synthesis of prostate specific membrane antigen (PSMA) ligands that are useful in the treatment of diseases like cancer. In particular, the disclosure relates to a method for synthesizing PSMA ligands having a glutamate-urea-lysine (GUL) moiety and a chelating agent that can comprise a radiometal.
    Type: Application
    Filed: November 19, 2021
    Publication date: January 25, 2024
    Inventor: Fritz ANDREAE
  • SYNTHESIS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS
    Publication number: 20240018099
    Abstract: The present disclosure relates to the synthesis of prostate specific membrane antigen (PSMA) ligands that are useful in the treatment of diseases like cancer. In particular, the disclosure relates to a method for synthesizing PSMA ligands having a glutamate-urea-lysine (GUL) moiety and a chelating agent that can comprise a radiometal.
    Type: Application
    Filed: November 19, 2021
    Publication date: January 18, 2024
    Inventor: Fritz ANDREAE
  • SYNTHESIS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS
    Publication number: 20240010623
    Abstract: The present disclosure relates to the synthesis of prostate specific membrane antigen (PSMA) ligands that are useful in the treatment of diseases like cancer. In particular, the disclosure relates to a method for synthesizing PSMA ligands having a glutamate-urea-lysine (GUL) moiety and a chelating agent that can comprise a radiometal.
    Type: Application
    Filed: November 19, 2021
    Publication date: January 11, 2024
    Inventor: Fritz ANDREAE